Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Today’s trading

<< Previous

Bullboard Posts

Next >>

Comment by scarlet1967on Feb 04, 2021 12:19pm

102 Views

Post# 32471024

RE:RE:RE:RE:RE:RE:RE:Today’s trading

In my opinion market isn't dumb on the contrary market is very clever so I wouldn't blame the market for higher SP.
The market needs convincing which is the issue with THTX not only for this PR but for any meaningful positive news.

jfm1330 wrote: This post and your previous one are not on a logical line. The SP is struggling after a great news and you don't understand why the management did the financing without that great news. Today's trading shows how dumb the market is. The FDA is clearly signaling the high potential of the oncology plaform and look at the SP.

jeffm34 wrote: Stock price struggling to stay above $3.50 CND. I wonder why that is